Targeted PU.1 Insertion for Pure Microglia Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating microglia from stem cells are time-consuming, inefficient, and often result in heterogeneous populations due to random integration of genetic material, leading to challenges in isolating pure microglia for research and therapeutic applications, particularly in neurodegenerative diseases.
Innovation Solution
A method involving targeted insertion of a nucleotide sequence encoding a transcriptional regulator protein and the coding sequence of the transcription factor PU.1 into specific genomic safe harbor sites, linked to an inducible promoter, followed by exposure to growth factors that mimic embryonic or adult microglia signaling, to control and stabilize the expression of PU.1, thereby producing a pure microglia population.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If random integration of genetic material is used to generate microglia from stem cells, then the generation process is simpler, but the resulting microglia population is heterogeneous and purification is difficult
Solution Approach 1:
The patent applies local quality by targeting specific genomic safe harbor sites (such as ROSA26 or AAVS1) for integrated gene insertion, rather than random integration. This ensures that the PU.1 transcription factor and other microglia-specific genes are inserted at predetermined locations with known chromatin accessibility and expression characteristics, resulting in homogeneous microglia populations with consistent gene expression profiles.
Solution Approach 2:
The patent employs preliminary action by pre-selecting and preparing genomic safe harbor sites before the actual gene integration step. The safe harbor sites are chosen in advance based on their favorable characteristics (open chromatin, low transcriptional interference), and the integration process is designed to target these pre-identified locations, ensuring high-quality microglia generation from the outset.
2Reliability
If conventional differentiation protocols are used to generate microglia, then the process is established, but it is time-consuming and inefficient
Solution Approach 1:
The patent applies preliminary action by pre-integrating the PU.1 transcription factor and other microglia-specific genes into the stem cell genome at safe harbor sites before differentiation. This preliminary genetic preparation eliminates the need for time-consuming subsequent steps to induce and maintain microglia-specific gene expression, allowing direct and rapid differentiation into pure microglia populations.
Solution Approach 2:
The patent extracts the essential microglia-specific gene expression program (centered on PU.1) and embeds it directly into the stem cell genome at safe harbor sites. This extraction and integration of the critical transcriptional regulator allows the stem cells to skip intermediate stages and differentiate directly into mature microglia, significantly reducing the time required compared to conventional stepwise differentiation protocols.
3Manufacturing precision
If targeted insertion at genomic safe harbor sites is used, then the microglia population purity is improved, but the method complexity increases
Solution Approach 1:
The patent uses an intermediary approach by employing lentiviral vectors as mediators to deliver the PU.1 and other microglia-specific genes to the stem cells. The lentiviral vector serves as a carrier that can efficiently transduce stem cells and integrate the genetic material at the designated safe harbor sites, simplifying the overall process compared to direct non-viral integration methods while maintaining high precision and purity.
Data Source
AI summary
The present invention relates to a method for the production of microglia from stem cells comprising the steps of a) targeted insertion of a nucleotide sequence encoding a transcriptional regulator protein into a first genomic safe harbour site; and b) targeted insertion of the coding sequence of the transcription factor PU.1 (SEQ ID NO: 1) into a second genomic safe harbour site, wherein the gene is operably linked to an inducible promoter, which is regulated by the transcriptional regulator protein; expression of PU.1 (SEQ ID NO: 2); and culturing the stem cells received from steps a) and b) with exposure to at least one growth factor or small molecule that mimics signaling during at least one stage of embryonic development of microglia or adult microglia proliferation, differentiation or polarization. Further, the present invention relates to the microglia obtained by the methods of the present invention and various uses thereof.